/   Home   /   Headline

China's New Drug Might Give Alzheimer Patients Hope: Lead Researcher

Oct 29, 2018     Email"> PrintText Size

GV-971, a multi-targeting oligosaccharide drug developed by a Chinese research group, could give Alzheimer patients hope, lead researcher Geng Meiyu told Xinhua on Thursday.

"If everything is confirmed in future studies, this can really give the world new hope," she said.

Geng, key inventor of the GV-971, presented the findings in a speech on Thursday at the 11th Clinical Trials on Alzheimer's Disease Conference (CTAD) being held in Barcelona until Oct. 27.

Alzheimer's disease is an irreversible, progressive brain disorder that slowly destroys memory, thinking skills, and the ability to carry out simple tasks. The disease affects about 48 million people worldwide, and the number is expected to increase with the aging population. There is no effective cure.

GV-971 was developed by Ocean University of China, Shanghai Institute of Materia Medica under Chinese Academy of Sciences and Green Valley Pharmaceutical Co., Ltd, after a 21-year study.

The drug completed phase 3 clinical trial in July this year. A phase three clinical trial is the last test before reaching the market.

In the trial, participants took 450 mg GV-971 orally twice a day for 36 weeks, which proved effective in improving cognition.

Extracted from brown algae, the drug is targeted at patients with mild-to-moderate Alzheimer's. Independent animal experiments also showed that it can regulate the immune system, reduce neuro-inflammation and improve cognition.

"In the future we will confirm our findings in human bodies," Geng said. The launch of a new drug like GV-971 would give hopes to patients not only in China but in other parts of the world, she added. (Xinhua)

(Editor: CHEN Na)



Related Articles

Alzheimer; Alzheimer's disease; AD; AD16; GIBH

China's New Alzheimer's Disease Drug Applies for Clinical Tests

May 25, 2015

China will begin clinical tests on a new drug for Alzheimer's disease (AD), after animal tests showed positive results. AD16, developed by Guangzhou Institute of Biomedicine and Health (GIBH) under the Chinese Academy of Sciences, has proven effective ...


Smart Soup, Traditional Chinese Medicine Formula, Ameliorates Alzheimer's Disease

Dec 05, 2014

Alzheimer's disease (AD) is a progressive and complex neurodegenerative disease with no effective and safe disease-modifying treatment and only symptomatic medical interventions available. Researchers led by Prof. PEI Gang from Institute of Biochemistr...

wearable device; neuron; brain disorder; optogenetics; Parkinson's disease; epilepsy

Scientists Develop Wearable Tech for Lab Mice to Help in Brain Disorder Research

May 13, 2015

Chinese researchers have developed the first wearable device that can control neuron activities in mice with light, to help in research into cures for common brain disorders such as Parkinson's disease and epilepsy.

Contact Us

Copyright © 2002 - Chinese Academy of Sciences